{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Ricky is one of the most appealing teenagers in my practice. Bright, funny and a genuinely cool kid, Ricky suffers from the worst case of attention deficit disorder with hyperactivity that I have seen in 14 years as a pediatrician. He is also prone to serious bouts of depression, poor self-esteem, forays into alcohol and marijuana abuse, and, at unpredictable junctures, violent outbursts.", "headline": {"main": "Growing Up on a Ritalin-Prozac Cocktail: Is This What Ricky Needs?", "kicker": "CASES"}, "abstract": "Dr Howard Markel article on his treatment of boy with what he says is worst case of attention deficit disorder with hyperactivity disorder, boy who also suffers from depression; says in six years he has been boy's pediatrician, he has noever seen him when he was not medicated with staggering combination of Ritalin, Prozac and, at different times, far stronger psychotropic drugs under the supervision of child psychiatrist; warns that there are many children for whom these drugs are bandages that only mask gaping psychic wounds, serious and poorly understood disorders of neurochemistry, and even counterproductive parenting techniques that give rise to complex and destructive behaviors; drawing (L)", "print_page": "6", "word_count": 1190, "_id": "4fd23b468eb7c8105d7cff20", "snippet": "Ricky is one of the most appealing teenagers in my practice.     Bright, funny and a genuinely cool kid, Ricky suffers from the worst case of attention deficit disorder with hyperactivity that I have seen in 14 years as a pediatrician. He is also...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/04/18/health/cases-growing-up-on-a-ritalin-prozac-cocktail-is-this-what-ricky-needs.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "RITALIN (DRUG)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "PROZAC (DRUG)"}, {"name": "subject", "value": "ATTENTION DEFICIT HYPERACTIVITY DISORDER"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Howard", "lastname": "MARKEL", "rank": 1, "role": "reported", "organization": ""}], "original": "By HOWARD MARKEL, M.D"}, "document_type": "article", "pub_date": "2000-04-18T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "In the two years since the revolutionary drug Viagra reached the market, the medical condition known as erectile dysfunction has gone from something that was the seldom mentioned cause of hidden misery and embarrassment to the basis of a billion-dollar-plus industry. Last week, an advisory committee to the Food and Drug Administration recommended that a second oral drug, called Uprima, join Viagra on the market to help men get and maintain erections. And at least a dozen additional drugs to treat male or female sexual performance problems are being developed by other companies.", "headline": {"main": "Impotence Is Given Another Name, and a Drug Market Grows"}, "abstract": "Erectile dysfunction has gone from something that was seldom mentioned to the basis of a billion-dollar-plus business in the two years since the drug Viagra reached market; advisory committee to FDA now recommends that second oral drug, called Uprima, join Viagra in the market; at least dozen additional drugs to treat male or female sexual performance problems are being developed by other companies; medical experts discuss role of social changes in emergence of new drugs; photo of Viagra pills; photo of Dr Ragab El-Rashidy, who discovered Uprima (L)", "print_page": "6", "word_count": 1771, "_id": "4fd236738eb7c8105d7c86a5", "snippet": "In the two years since the revolutionary drug Viagra reached the market, the medical condition known as erectile dysfunction has gone from something that was the seldom mentioned cause of hidden misery and embarrassment to the basis of a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/04/18/health/impotence-is-given-another-name-and-a-drug-market-grows.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "EL-RASHIDY, RAGAB"}, {"name": "subject", "value": "UPRIMA (DRUG)"}, {"name": "subject", "value": "SEX"}, {"name": "subject", "value": "IMPOTENCE"}, {"name": "subject", "value": "VIAGRA (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2000-04-18T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Biography", "blog": [], "news_desk": "Magazine Desk", "lead_paragraph": "One of the ways in which the very rich are different from you and me is that they become public property. Just about everyone has an opinion about Bill Gates's business tactics, products, motives, character, house -- and about what he should be doing with his immense fortune. Before he began giving money away, people complained that he was a miser. Now that he is giving money away, they complain that he's doing it too late, that he isn't giving enough, that he hasn't a clue about what he's getting into, that the projects he is financing are too conservative, too liberal, too big, too small, too safe, too risky, too conventional, too splashy. Or they say he's only doing it to avoid taxes, or to expand Microsoft's markets, or, especially, to improve his image in light of the government's high-profile antitrust suit.", "headline": {"main": "How to Give Away $21.8 Billion"}, "abstract": "Jean Strouse article on Bill and Melinda Gates Foundation as centerpiece of Gates's philanthropic endeavors; billions of dollars already in foundation coffers are administered by Bill Gates's longtime associate Patty Stonesifer, with help from Bill Gates Sr; photos; Gates, who has always said he plans to give away most of his fortune before he dies, is still primarily involved with his company, and considers himself 'very early' on learning curve of philanthropy; difficult decisions on allocating huge amounts of money discussed; list of major beneficiaries (L)", "print_page": "56", "word_count": 8168, "_id": "4fd212f78eb7c8105d789a0b", "snippet": "One of the ways in which the very rich are different from you and me is that they become public property. Just about everyone has an opinion about Bill Gates's business tactics, products, motives, character, house -- and about what he should be doing...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/04/16/magazine/how-to-give-away-21.8-billion.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GATES, WILLIAM H JR"}, {"name": "persons", "value": "GATES, WILLIAM H SR"}, {"name": "persons", "value": "STONESIFER, PATTY"}, {"name": "persons", "value": "GATES, MELINDA"}, {"name": "organizations", "value": "GATES, BILL AND MELINDA, FOUNDATION"}, {"name": "organizations", "value": "MICROSOFT CORP"}, {"name": "subject", "value": "COMPANY AND ORGANIZATION PROFILES"}, {"name": "subject", "value": "PHILANTHROPY"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Jean", "lastname": "Strouse"}], "original": "By Jean Strouse"}, "document_type": "article", "pub_date": "2000-04-16T00:00:00Z", "section_name": "Magazine"}], "meta": {"hits": 3, "offset": 0, "time": 39}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}